|
WO2020065563A1
|
|
Injection device
|
|
EP3653244A1
|
|
A device for mounting a syringe needle to a syringe barrel
|
|
US2019233620A1
|
|
Cyclodextrin-grafted cross-linked hyaluronic acid complexed with active drug substances and uses thereof
|
|
EP3415099A1
|
|
Medical muiltiple skin biopsy device
|
|
CN109641975A
|
|
Method for cracking amido bond
|
|
US2020030219A1
|
|
Method for preparing acylated crosslinked glycosaminoglycans
|
|
EP3377063A1
|
|
Use of ivermectin and brimonidine in the treatment and/or prevention of moderate to severe rosacea
|
|
US2018296482A1
|
|
Process for preparing a composition comprising a high concentration of one or more avermectins
|
|
US2018289732A1
|
|
A process for preparing a stable emulsion comprising one or more avermectins
|
|
WO2017029387A1
|
|
Method of improving visual appearance of nails affected by onychomycosis
|
|
US2018223053A1
|
|
A process for efficient cross-linking of hyaluronic acid
|
|
EP3319607A1
|
|
Method of reducing hair loss associated with chemotherapy
|
|
EP3252080A1
|
|
Method for preparing acylated crosslinked glycosaminoglycans
|
|
EP3252081A1
|
|
Hydrolysis of ester bonds in amide crosslinked glycosaminoglycans
|
|
EP3252082A1
|
|
Method for deacetylation of biopolymers
|
|
WO2016162493A1
|
|
Treatment of paronychia with indigo naturalis or indigo-producing plant extract
|
|
US2018110819A1
|
|
Antibacterial indigo naturalis or indigo-producing plant extract and use thereof
|
|
EP3215169A1
|
|
Treatment of atopic dermatitis with indigo naturalis or indigo producing plant extract
|
|
WO2016162489A1
|
|
Treatment of nail disorder with an indigo naturalis or indigo-producing plant extract
|
|
WO2016162486A1
|
|
Treatment of candidiasis with indigo naturalis or indigo-producing plant extract
|
